Daniel Iazzetti was Resigned as Executive Director of Human Resources at Five Prime Therapeutics

Date of management change: October 15, 2019 

What Happened?

South San Francisco, CA-based Five Prime Therapeutics Resigned Daniel Iazzetti as Executive Director of Human Resources


About the Company

Five Prime Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of protein therapeutics that block cancer and inflammatory disease processes. The company`s product candidates include FP-1039/GSK3052230, a protein therapeutic is in PhaseIb clinical trials for trapping and neutralizing cancer-promoting fibroblast growth factors (FGFs) involved in cancer cell proliferation and new blood vessel formation; FPA008, an antibody that inhibits colony stimulating factor-1 receptor; and FPA144 is an antibody for inhibiting FGF receptor 2b, as well as to treat patients with gastric cancer and potentially other solid tumors. It has collaboration and license agreements with GlaxoSmithKline LLC, Glaxo Group Limited, GSK-HGS, Pfizer Inc., and UCB Pharma S.A. The company was founded in 2001 and is headquartered in South San Francisco, California.


About the Person

Daniel Iazzetti is Vice President of Human Resources at Angion. Previously, Daniel held various senior HR leadership roles in the industry.


Info Source



Other IT executives who recently changed jobs as well: Barker Julie, Stark Tom, Lifshitz Eyal, Oscilowski Patricia, Brogan Frank, Jenkins Shirl, Carr Heather, Spessard Rhonda, Rosenthal Chloe, Benton Rhanetta, Kurien Anju

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.